EP Patent

EP4345100A3 — Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2

Assigned to Auspex Pharmaceuticals Inc · Expires 2024-04-10 · 2y expired

What this patent protects

Disclosed are crystalline forms of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2, pharmaceutical compositions and uses thereof.

USPTO Abstract

Disclosed are crystalline forms of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2, pharmaceutical compositions and uses thereof.

Drugs covered by this patent

Patent Metadata

Patent number
EP4345100A3
Jurisdiction
EP
Classification
—
Expires
2024-04-10
Drug substance claim
No
Drug product claim
No
Assignee
Auspex Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.